|
項目
|
作者
|
文章標題
|
期刊
|
|
1
|
Chen CY, Huang SS, Ou SM, Ho Y, Chen TH, Lee KH, Chu YC, Lin YP, Tseng WC*, Tarng DC*.
|
Excessive Initial Renal Function Decline Following Sodium-Glucose Cotransporter-2 Inhibitor Treatment Predicts Major Adverse Cardiorenal Outcomes.
|
Mayo Clin Proc. 2025 Feb;100(2):204-219.
|
|
2
|
Chen TH, Ho Y, Tai HL, Chu YC, Lin YP, Yang CY, Tseng WC, Ou SM, Tsai MT, Chen JY, Wu TH, Lee KH, Chen FY, Li SY, Lin CC, Tarng DC*.
|
Survival benefit of a third dose of the COVID-19 vaccine among hemodialysis patients: A prospective cohort study.
|
J Microbiol Immunol Infect. 2023 Dec;56(6):1198-1206.
|
|
3
|
Ho Y, Chen TW, Huang TP, Chen YH*, Tarng DC*
|
Bilirubin Links HO-1 and UGT1A1*28 Gene Polymorphisms to Predict Cardiovascular Outcome in Patients Receiving Maintenance Hemodialysis.
|
Antioxidants. 2021; 10(9):1403.
|
|
4
|
Lee KH, Ho Y, Tarng DC*
|
Iron Therapy in Chronic Kidney Disease: Days of Future Past.
|
International Journal of Molecular Sciences. 2021; 22(3):1008.
|
|
5
|
Yang CW, Chen FY, Chang FP, Ho Y, Wu BS, Yang AH, Tarng DC, Yang CY*
|
IgM mesangial deposition as a risk factor for relapses of adult-onset minimal change disease.
|
BMC Nephrol. 2021 Jan 12;22(1):25.
|
|
6
|
Wu BS, Ho Y, Yang CY*
|
A Nautilus kidney.
|
Clin Exp Nephrol. 2020 Oct;24(10):971-972.
|
|
7
|
Yang CY, Wang YF, Ho Y, Wu CH, Lee CY, Tarng DC*
|
Hemodialysis vascular access care during the COVID-19 pandemic.
|
J Chin Med Assoc. 2020 Jul;83(7):634-638.
|